Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chaim Hurvitz Insider Profile
11 Followers
Chaim Hurvitz, Director at NRX Pharmaceuticals, holds 2.21M shares in NRX Pharmaceuticals (Ticker: NRXP), holds ― shares in Dror Ortho-Design (Ticker: DROR). Most recently, Chaim Hurvitz Bought ― shares of NRX Pharmaceuticals on Sep 11, 2023 for an estimated value of 19.60K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-45.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Chaim Hurvitz holds in companies
Most Profitable Insider Trade
The most profitable trade made by Chaim Hurvitz
Chaim Hurvitz's Trading History
NRX Pharmaceuticals
Sep 11, 2023
Director
Informative Buy
19.60K
$6.22M
Dror Ortho-Design
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Chaim Hurvitz's performance on stock
You May Also Like
Chaim Hurvitz insider profile FAQ
What is the percentage of profitable transactions made by Chaim Hurvitz?
The percentage of profitable transactions made by Chaim Hurvitz is 0%.
What is the average return per transaction made by Chaim Hurvitz?
The average return per transaction made by Chaim Hurvitz is -45.20%.
What stocks does Chaim Hurvitz hold?
Chaim Hurvitz holds: NRXP, DROR stocks.
What was Chaim Hurvitz’s latest transaction?
Chaim Hurvitz latest transaction was an Informative Buy of $19.60K.
What was Chaim Hurvitz's most profitable transaction?
Chaim Hurvitz’s most profitable transaction was an Informative Buy of NRXP stock on September 11, 2023. The return on the trade was -19.80%.
What is Chaim Hurvitz's role in NRX Pharmaceuticals?
Chaim Hurvitz's role in NRX Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.